A program for transgender adults to support recovery from substance use and HIV risk

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests the TLC program, a mutual-help group designed for transgender adults who use substances or are in recovery. The program is based on Acceptance and Commitment Therapy (ACT), which utilizes mindfulness skills to help participants connect with their values and improve mental health. Developed collaboratively by transgender community members, mental health providers, and researchers, the TLC program aims to address the unique challenges faced by transgender individuals, including stigma and its impact on substance use and HIV risk. The study seeks to evaluate the effectiveness of this program in reducing substance misuse and improving health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Eligible transgender adults must:

1. be 18 years of age or older;
2. speak primarily English;
3. live in the U.S.;
4. have a gender identity different from their assumed gender, or sex assigned, at birth;
5. identify as a person of transgender experience;
6. endorse having experienced two or more problem(s) related to alcohol or other drug use within the past 12 months.

Where it's running

• Illinois Institute of Technology
  Chicago, Illinois, United States Recruiting

Study contacts

• Study coordinator: Arryn Guy, PhD
• Email: aguy1@iit.edu
• Phone: 312-567-6467

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cervical screening and care options for women living with HIV who test positive for high-risk HPV

  This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.

  Recruiting University of California, San Diego · Nairobi · NCT07925307

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• Real-time fMRI Neurofeedback for Anhedonia in Methadone-Treated Opioid Use Disorder

  This feasibility study tests a real-time fMRI neurofeedback approach to see if it helps reduce anhedonia in people on methadone for opioid use disorder.

  Recruiting Yale University · New Haven, Connecticut · NCT07768007

• Psilocybin Therapy for MeUD and HIV

  This study tests whether a single psilocybin dose, paired with motivational support therapy, can help people with HIV and moderate-to-severe methamphetamine use disorder stop using methamphetamine.

  Recruiting Phase 2 University of California, San Francisco · San Francisco, California · NCT07756736

• Trauma recovery options for veterans: comparing HRV biofeedback and present-centered therapy

  This trial tests whether Heart Rate Variability Biofeedback plus trauma-informed care helps veterans with PTSD and substance use issues more than present-centered therapy.

  Recruiting Phase 2/3 Coatesville VA Medical Center · Coatesville, Pennsylvania · NCT07756723

• Mindfulness-Based Relapse Prevention for Peer Workers

  We’re testing whether Mindfulness-Based Relapse Prevention can help substance-use peer workers cut down on use and burnout compared with usual referrals to a 12-step program.

  Recruiting University of Texas at Austin · Austin, Texas · NCT07741825

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.